NIH-funded research Career grant

Understanding how specific proteins influence blood cell development

Official title: The molecular mechanisms underlying context-specific Runx factor functions in directing hematopoietic cell identity

Funded at California Institute of Technology · NIH-10866170 · Data updated 2026-11-12

This study is looking at how certain proteins help make blood cells, especially T cells that fight infections and megakaryocytes that help with blood clotting, to better understand how these cells develop and what happens when things go wrong.

Quick facts

Grant typeCareer grant
Study typeNIH-funded research
Funding institutionCalifornia Institute of Technology
NIH-funded
Lab location1 site (Pasadena, United States)
Project startSeptember 17, 2024
Project endJune 30, 2026
Funding year2024
Award (this year)$95,315
NIH project number1K99HL173688-01
Project IDNIH-10866170 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals with blood disorders or those interested in the mechanisms of blood cell development.

Less likely to help

Patients with conditions unrelated to blood cell development or those not affected by hematological issues may not benefit from this research.

What this research studies

This research investigates the molecular mechanisms that guide the development of blood cells, focusing on how certain proteins, known as transcription factors, regulate gene expression in different contexts. By studying the Runx transcription factors, the research aims to uncover their roles in the development of T cells and megakaryocytes, which are crucial for immune function and blood clotting, respectively. The project utilizes innovative cell culture techniques to mimic the early stages of blood cell development, allowing for a deeper understanding of these processes. This could lead to insights into both normal blood cell formation and conditions where this process goes awry.

Why it matters

Potential benefit: If successful, this research could lead to improved treatments for blood-related disorders, including leukemia and other hematological conditions.

How similar studies have gone: Previous research has shown promising results in understanding transcription factors' roles in cell development, suggesting that this approach could yield valuable insights.

Where this research is happening

  • California Institute of Technology
    Pasadena, United States
    Active

Researchers

  • Principal investigator: Shin, Boyoung — California Institute of Technology
  • Study coordinator: Shin, Boyoung

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.